These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19458497)

  • 1. Aptamers and aptamer targeted delivery.
    Yan AC; Levy M
    RNA Biol; 2009; 6(3):316-20. PubMed ID: 19458497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers as therapeutics.
    Keefe AD; Pai S; Ellington A
    Nat Rev Drug Discov; 2010 Jul; 9(7):537-50. PubMed ID: 20592747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of synthetic nucleic acid aptamers.
    Poolsup S; Kim CY
    Curr Opin Biotechnol; 2017 Dec; 48():180-186. PubMed ID: 28582756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapy.
    Aaldering LJ; Tayeb H; Krishnan S; Fletcher S; Wilton SD; Veedu RN
    RNA Biol; 2015; 12(4):412-25. PubMed ID: 25849197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expected and unexpected features of protein-binding RNA aptamers.
    Bjerregaard N; Andreasen PA; Dupont DM
    Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):744-757. PubMed ID: 27173731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the interface of nucleic acid aptamers and binding targets.
    Cai S; Yan J; Xiong H; Liu Y; Peng D; Liu Z
    Analyst; 2018 Nov; 143(22):5317-5338. PubMed ID: 30357118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
    Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
    RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric aptamers in cancer cell-targeted drug delivery.
    Kanwar JR; Roy K; Kanwar RK
    Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA plasticity and selectivity applicable to therapeutics and novel biosensor development.
    Nakamura Y; Ishiguro A; Miyakawa S
    Genes Cells; 2012 May; 17(5):344-64. PubMed ID: 22487172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.
    Mallikaratchy P
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28146093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combined ELONA-(RT)qPCR Approach for Characterizing DNA and RNA Aptamers Selected against PCBP-2.
    Moreno M; Fernández-Algar M; Fernández-Chamorro J; Ramajo J; Martínez-Salas E; Briones C
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30925703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid aptamers: clinical applications and promising new horizons.
    Ni X; Castanares M; Mukherjee A; Lupold SE
    Curr Med Chem; 2011; 18(27):4206-14. PubMed ID: 21838685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid aptamers as high affinity ligands in biotechnology and biosensorics.
    Šmuc T; Ahn IY; Ulrich H
    J Pharm Biomed Anal; 2013; 81-82():210-7. PubMed ID: 23666257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid aptamers: research tools in disease diagnostics and therapeutics.
    Santosh B; Yadava PK
    Biomed Res Int; 2014; 2014():540451. PubMed ID: 25050359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamers: multifunctional molecules for biomedical research.
    Banerjee J; Nilsen-Hamilton M
    J Mol Med (Berl); 2013 Dec; 91(12):1333-42. PubMed ID: 24045702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and thermodynamics of Drug-RNA aptamer interactions.
    Da Costa JB; Dieckmann T
    Mini Rev Med Chem; 2013 Apr; 13(4):467-77. PubMed ID: 23095001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamers and SELEX in Chemistry & Biology.
    Famulok M; Mayer G
    Chem Biol; 2014 Sep; 21(9):1055-8. PubMed ID: 25237853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers.
    Bell DR; Weber JK; Yin W; Huynh T; Duan W; Zhou R
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8486-8493. PubMed ID: 32234785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.